Regulatory Timelines for Clinical Trial Approvals in India
Regulatory Timelines for Clinical Trial Approvals in India Understanding India’s Clinical Trial Approval Timelines Under NDCTR 2019 Introduction Timely clinical trial initiation is critical for drug development, especially in a competitive and globally integrated pharmaceutical landscape. For sponsors and Contract Research Organizations (CROs) considering India as a trial destination, a clear understanding of the country’s…
Read More “Regulatory Timelines for Clinical Trial Approvals in India” »